Production (Stage)
OS Therapies Incorporated
OSTX
$1.67
$0.042.45%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.88M | -2.99M | -2.88M | -1.56M | -1.46M |
| Total Depreciation and Amortization | 700.00 | 1.40K | 0.00 | 700.00 | 700.00 |
| Total Amortization of Deferred Charges | -- | 0.00 | 338.30K | 508.70K | -- |
| Total Other Non-Cash Items | 733.50K | 301.80K | -- | -- | 578.70K |
| Change in Net Operating Assets | -299.30K | 313.40K | -847.90K | 166.90K | 237.80K |
| Cash from Operations | -3.44M | -2.37M | -3.38M | -881.20K | -641.70K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -173.60K | -- | -- | -- | -- |
| Cash from Investing | -173.60K | -- | -- | -- | -- |
| Total Debt Issued | -- | 0.00 | 0.00 | 900.00K | 851.00K |
| Total Debt Repaid | -- | 0.00 | -250.00K | -- | -- |
| Issuance of Common Stock | -- | 0.00 | 5.23M | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 1.05M | 6.05M | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 172.10K | -24.10K | -148.00K |
| Cash from Financing | 1.05M | 6.05M | 5.15M | 875.90K | 703.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.56M | 3.68M | 1.76M | -5.30K | 61.20K |